Understanding and Controlling of Immunotoxicity of Nanomaterials

A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".

Deadline for manuscript submissions: 25 November 2024 | Viewed by 23

Special Issue Editor


E-Mail Website
Guest Editor
National Research Council Italy-CNR, Institute of Science and Technology for Ceramics-ISTEC, Via Granarolo 64, 48018 Faenza, RA, Italy
Interests: nanoscience; Bayesian risk assessment; biomimetic membranes; nano-electrochemistry
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Human and environmental exposure to nanomaterials has become an unavoidable reality. The expansion of nanotechnology means that products featuring nanoparticles as functional or supporting materials are now a part of our day-to-day lives. Understanding of the ways that nanomaterials interact with biological systems is crucial, that we might anticipate biological risks and establish criteria for designing nanomaterials and nano-enabled products that are as safe as possible.

After decades of research, we have identified factors that lead to the adverse interaction of nanomaterials with biological systems; this knowledge provides the basis for conceptual frameworks within which to assess and manage the risks of using nanomaterials. As often occurs in scientific research, improved knowledge of immunotoxicology has brought still unresolved uncertainties to the fore: the physicochemical heterogeneity of nanoparticles does not allow us to draw more general conclusions; the details of nanomaterials’ interactions with cells and organisms are largely unknown; and the transformation of nanoparticles moving through different biological compartments makes it extremely difficult to establish safe amounts. As of today, these uncertainties still prevent the adoption of effective regulatory and protective rules. With the aim of marking a further step towards understanding and controlling the immunotoxicity of nanomaterials (which is a multi-faceted objective), this Special Issue collates a series of original articles focusing on new findings in immunotoxicity, including theoretical and experimental methods for understanding the interaction of nanoparticles with biological systems, statistical methods of estimating risk, and strategies for mitigating the risks posed by hazardous nanoparticles.

We look forward to receiving your contributions.

Dr. Felice Carlo Simeone
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • physicochemical drivers of hazards
  • mechanisms of hazards
  • pathways of adverse outcomes
  • modelling of risk
  • immunotoxicity
  • nanotoxicology
  • dosimetry
  • risk assessment
  • change grouping strategies
  • safety by design

Published Papers

This special issue is now open for submission.
Back to TopTop